Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Revenue: NT$569.6 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4747 Johnson Chemical Pharmaceutical Works Co ROCO:4747
70 GF Score
Price NT$28.25
GF Value NT$30.96
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Johnson Chemical Pharmaceutical Works Co Revenue?

Johnson Chemical Pharmaceutical Works Co ROCO:4747 +6.60% 70 Revenue is NT$569.6 Mil as of Mar. 2026. GuruFocus rates ROCO:4747 with a GF Score™ of 70/100 and a GF Value™ of NT$30.96 (Fairly Valued). The stock has 8 warning signs investors should review.

Johnson Chemical Pharmaceutical Works Co's revenue for the three months ended in Mar. 2026 was NT$146.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NT$569.6 Mil. Johnson Chemical Pharmaceutical Works Co's Revenue per Share for the three months ended in Mar. 2026 was NT$1.58. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$6.20.

Warning Sign:

Johnson Chemical Pharmaceutical Works Co revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Johnson Chemical Pharmaceutical Works Co was -4.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -6.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Johnson Chemical Pharmaceutical Works Co's highest 3-Year average Revenue per Share Growth Rate was 17.20% per year. The lowest was -6.40% per year. And the median was 2.55% per year.


Johnson Chemical Pharmaceutical Works Co  (ROCO:4747) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Johnson Chemical Pharmaceutical Works Co Revenue Related Terms


Johnson Chemical Pharmaceutical Works Co Revenue Historical Data

* Premium members only.

The historical data trend for Johnson Chemical Pharmaceutical Works Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson Chemical Pharmaceutical Works Co Revenue Chart

Johnson Chemical Pharmaceutical Works Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 411.49 494.67 606.71 611.42 569.77

Johnson Chemical Pharmaceutical Works Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.79 138.19 134.26 150.53 146.59

ROCO:4747 vs ZTS: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Johnson Chemical Pharmaceutical Works Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson Chemical Pharmaceutical Works Co Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson Chemical Pharmaceutical Works Co's Revenue distribution charts can be found below:

* The bar in red indicates where Johnson Chemical Pharmaceutical Works Co's Revenue falls into.


ROCO:4747
70GF Score
Johnson Chemical Pharmaceutical Works Co ROCO:4747
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson Chemical Pharmaceutical Works Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$569.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of NT$569.6 Mil mean?
Johnson Chemical Pharmaceutical Works Co (ROCO:4747) has a Revenue of NT$569.6 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Johnson Chemical Pharmaceutical Works Co and its competitors.
Is Johnson Chemical Pharmaceutical Works Co's Revenue too high?
Johnson Chemical Pharmaceutical Works Co's current Revenue is NT$569.6 Mil. Overall, Johnson Chemical Pharmaceutical Works Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Johnson Chemical Pharmaceutical Works Co's Revenue compare to ZTS?
Johnson Chemical Pharmaceutical Works Co's Revenue of NT$569.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Johnson Chemical Pharmaceutical Works Co and its competitors. Johnson Chemical Pharmaceutical Works Co's current Revenue is NT$569.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Chemical Pharmaceutical Works Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Chemical Pharmaceutical Works Co (ROCO:4747) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.96, compared to a current price of NT$28.25 — trading 8.8% below its estimated fair value. The current Revenue is NT$569.6 Mil. Johnson Chemical Pharmaceutical Works Co's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Johnson Chemical Pharmaceutical Works Co (ROCO:4747), the current Revenue is NT$569.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson Chemical Pharmaceutical Works Co stock appears to be undervalued. The current stock price of NT$28.25 is trading 8.8% below its estimated GF Value™ of NT$30.96. GuruFocus considers Johnson Chemical Pharmaceutical Works Co to be Fairly Valued.

Key valuation signals for ROCO:4747:

  • Revenue: NT$569.6 Mil
  • GF Value™: NT$30.96 vs. price of NT$28.25 (8.8% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson Chemical Pharmaceutical Works Co Business Description

Address Sanhe Road, No. 77 and No. 79, Section 4, Sanchong District, New Taipei City, TWN, 241
Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients, importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. Its revenue mainly comes from medical product sales.
70GF Score

Get the complete analysis for ROCO:4747

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.25
Price
NT$30.96
GF Value